about
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-medi...
Read More1.6M XNAS Volume
XNAS 09 Jun, 2025 5:30 PM (EDT)
Board Meeting
The board meeting for Cabaletta Bio Inc is scheduled for today, for the purpose of Cabaletta Bio Inc Annual General Meeting for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Cabaletta Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..